Highland Capital Management LLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 66.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,915 shares of the biotechnology company's stock after selling 5,649 shares during the quarter. Highland Capital Management LLC's holdings in Axon Enterprise were worth $1,732,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in AXON. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock valued at $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC grew its holdings in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after purchasing an additional 44 shares during the period. Versant Capital Management Inc grew its holdings in shares of Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after purchasing an additional 95 shares during the period. Berbice Capital Management LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $59,000. Finally, Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $41,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Insider Transactions at Axon Enterprise
In related news, insider Jeffrey C. Kunins sold 21,834 shares of the firm's stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company's stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the company. Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Finally, JMP Securities upped their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $524.85.
Get Our Latest Report on AXON
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON traded up $9.09 on Friday, hitting $662.52. The company's stock had a trading volume of 53,442 shares, compared to its average volume of 539,157. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The company has a market capitalization of $50.52 billion, a price-to-earnings ratio of 171.19, a price-to-earnings-growth ratio of 6.41 and a beta of 1.04. The stock's 50-day moving average is $619.32 and its two-hundred day moving average is $479.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
